Skip to content

Effect of virtual reality combined with mindfulness therapy on anxiety symptoms in patients with arteriosclerotic obliterans and their caregivers

Effect of virtual reality combined with mindfulness therapy on anxiety symptoms in patients with arteriosclerotic obliterans and their caregivers

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081486
Enrollment
Unknown
Registered
2024-03-04
Start date
2024-03-05
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis obliterans

Interventions

treatment group:vr mindfulness Breathing combined meditation training
cobtrol group:vr mindfulness Breathing combined meditation training

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria in the guidelines for diagnosis and treatment of lower extremity arteriosclerosis obliterans; 2) Lower extremity arteriography showed arterial stenosis or occlusion; 3) GAD-7 screening indicates mild or moderate anxiety symptoms; 4) Age: 18-65 years old; 5) Handedness: right-handedness; 6) Culture: primary school graduation or above; 7) Race: Han; 8) Subjects are required to be socially functional and have full behavioral and responsibility capabilities 9) Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) The DSM-V tool was used to conduct interviews with patients who were eligible for major depressive episode, bipolar disorder, schizoaffective disorder, obsessive-compulsive disorder, organic mental disorder, substance-related mental disorder or diagnosed with other mental disorders, as well as patients with other cognitive disorders such as mental retardation and personality disorders; 2) Substance abusers; 3) Patients with color blindness, color weakness, deafness, stuttering, etc. that affect neurocognitive tests; 4) Be pregnant within 1 year; 5) electroconvulsive therapy within 6 months; 6) Regular meditation or yoga practice within the last 1 month; 7) Complained of discomfort when using VR devices.

Design outcomes

Primary

MeasureTime frame
anxiety symptoms ;

Secondary

MeasureTime frame
Mindfulness level;

Countries

China

Contacts

Public ContactYang Xu

The First Hospital of China Medical University

31725625@qq.com+86 139 9889 1151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026